T Cell Initiated Gastric Pathology

T 细胞引发的胃病理学

基本信息

项目摘要

DESCRIPTION (provided by applicant): The bacteria Helicobacter pylori is a major pathogen which, in addition to infecting over half of the world's population, is linked to gastric and duodenal ulcer disease, mucosal-associated lymphomas, and adenocarcinoma. Infection with H. pylori results in an early gastric infiltration of neutrophils, macrophages, CD4+ T cells, and B cells. These gastric infiltrates are accompanied by increased levels of gastric IFN-gamma, TNF-alpha, and IL-1 and by loss of gastric parietal cells, zymogenic cells, and dysplasia of gastric mucosal cells. Very little is known about the mechanisms by which this gastric infiltrate induces subsequent gastric epithelial pathology. A small animal model of Helicobacter infection, the H. felis mouse model, closely mimics the human disease in that severe gastric atrophy and gastric adenocarcinoma develops after infection. This model has allowed a careful analysis of the adaptive immune response to Helicobacter infection. Using a novel adoptive transfer model of disease, we have shown that it is the host CD4+ T cell response which is crucial for the development of H. felis-associated gastric pathology. This has directed our attention to the role of the CD4+ T cell, and its potential effector mechanisms, in the development of Helicobacter-associated gastric epithelial cell destruction and pathology. This grant application focuses on the hypothesis that recruitment and activation of CD4+ T cells in the stomach results in secondary non-antigen specific gastric epithelial cell alterations. These changes in epithelial cell proliferation and differentiation lead to gastric dysplasia and cancer formation. In order to elucidate this immune/ epithelial cell relationship and its sequelae, we propose to: 1) characterize the antigen recognition requirements of the CD4+ T cell critical for the development of Helicobacter-associated gastric pathology; and 2) determine the role of secreted or cell-surface products in the generation of Helicobacter-associated gastric epithelial pathology. These studies will utilize both in vivo models of disease, as well as a novel primary gastric epithelial cell culture system. The understanding of the basic mechanisms by which the host immune response to Helicobacter induces gastric epithelial pathology will lay the foundation for further studies on the regulation of the inflammatory response and the design of immunotherapies for Helicobacter infection and associated digestive diseases.
描述(由申请人提供):幽门螺杆菌是一种主要病原体,除了感染世界上一半以上的人口外,还与胃和十二指肠溃疡疾病、粘膜相关淋巴瘤和腺癌有关。螺杆菌感染幽门螺杆菌导致中性粒细胞、巨噬细胞、CD 4 + T细胞和B细胞的早期胃浸润。这些胃浸润伴随着胃IFN-γ、TNF-α和IL-1水平的增加以及胃壁细胞、酶原细胞和胃粘膜细胞发育不良的丧失。关于这种胃浸润诱导随后的胃上皮病理学的机制知之甚少。一个小的动物模型的螺杆菌感染,H。猫小鼠模型,在感染后发生严重胃萎缩和胃腺癌方面与人类疾病非常相似。该模型允许仔细分析对螺杆菌感染的适应性免疫应答。利用一种新的过继性疾病转移模型,我们已经证明宿主CD 4 + T细胞应答对H.猫相关胃病理学。这使我们的注意力转向CD 4 + T细胞的作用,及其潜在的效应机制,在幽门螺杆菌相关的胃上皮细胞破坏和病理的发展。这项拨款申请的重点是假设招募和激活的CD 4 + T细胞在胃中的结果在继发性非抗原特异性胃上皮细胞的改变。上皮细胞增殖和分化的这些变化导致胃异型增生和癌形成。为了阐明这种免疫/上皮细胞关系及其后遗症,我们建议:1)表征对螺杆菌相关胃病理学发展至关重要的CD 4 + T细胞的抗原识别要求; 2)确定分泌或细胞表面产物在螺杆菌相关胃上皮病理学产生中的作用。这些研究将利用体内疾病模型以及新型原代胃上皮细胞培养系统。了解宿主对螺杆菌的免疫反应诱导胃上皮病理的基本机制,将为进一步研究炎症反应的调节以及螺杆菌感染及相关消化系统疾病的免疫治疗设计奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robinna Gail Lorenz其他文献

Robinna Gail Lorenz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robinna Gail Lorenz', 18)}}的其他基金

Southeastern Medical Scientist Symposium
东南医学家研讨会
  • 批准号:
    9327579
  • 财政年份:
    2017
  • 资助金额:
    $ 27.55万
  • 项目类别:
Southeastern Medical Scientist Symposium
东南医学家研讨会
  • 批准号:
    8842667
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Preparation for Graduate and Medical Education(PreGAME)Program
研究生和医学教育准备(PreGAME)计划
  • 批准号:
    9257456
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Southeastern Medical Scientist Symposium
东南医学家研讨会
  • 批准号:
    8651000
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Preparation for Graduate and Medical Education(PreGAME)Program
研究生和医学教育准备(PreGAME)计划
  • 批准号:
    8829327
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
Preparation for Graduate and Medical Education(PreGAME)Program
研究生和医学教育准备(PreGAME)计划
  • 批准号:
    8612197
  • 财政年份:
    2014
  • 资助金额:
    $ 27.55万
  • 项目类别:
EPITHELIAL AND INNATE SENSORS OF THE MICROBIOTA IN IBD
IBD 微生物群的上皮细胞和先天传感器
  • 批准号:
    7486782
  • 财政年份:
    2007
  • 资助金额:
    $ 27.55万
  • 项目类别:
EPITHELIAL AND INNATE SENSORS OF THE MICROBIOTA IN IBD
IBD 微生物群的上皮细胞和先天传感器
  • 批准号:
    6959577
  • 财政年份:
    2005
  • 资助金额:
    $ 27.55万
  • 项目类别:
T Cell Initiated Gastric Pathology
T 细胞引发的胃病理学
  • 批准号:
    6696919
  • 财政年份:
    2003
  • 资助金额:
    $ 27.55万
  • 项目类别:
T Cell Initiated Gastric Pathology
T 细胞引发的胃病理学
  • 批准号:
    6832252
  • 财政年份:
    2003
  • 资助金额:
    $ 27.55万
  • 项目类别:

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 27.55万
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 27.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 27.55万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 27.55万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 27.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 27.55万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 27.55万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 27.55万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 27.55万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 27.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了